Melphalan and Hydrocortisone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Melphalan (melphalan) and Hydrocortisone (hydrocortisone). Common drug interactions include infusion related reaction among females and lung infiltration among males.
The phase IV clinical study analyzes what interactions people have when they take Melphalan and Hydrocortisone. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.
What is Melphalan?
Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.
What is Hydrocortisone?
Hydrocortisone has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 40,425 Hydrocortisone users. Check the latest studies of Hydrocortisone.
75 people who take Melphalan and Hydrocortisone together, and have interactions are studied.

What are the common drug interactions of Melphalan and Hydrocortisone, by gender? *:
female:
- Infusion related reaction
- Lung disorder (lung disease)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
- Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
- Periorbital oedema (swelling around the eyes)
- Abdominal distension
- Acute respiratory distress syndrome
- Disseminated intravascular coagulation (systemic activation of blood coagulation)
- Dyspnoea (difficult or laboured respiration)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
male:
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
- Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
- Pruritus (severe itching of the skin)
- Hypoxia (low oxygen in tissues)
- Mucosal inflammation (infection of mucous membrane)
- Pain
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Bacterial toxaemia (blood contains bacterial toxins)
- Lung disorder (lung disease)
- Neuropathy peripheral (surface nerve damage)
What are the common drug interactions of Melphalan and Hydrocortisone, by age (0-1 to 60+)? *:
0-1:
- Cerebral vasoconstriction (constriction of brain blood vessels)
- Hypertension (high blood pressure)
- Ileus (a painful obstruction of the ileum or other part of the intestine)
- Oesophageal squamous cell carcinoma (cancer that begins in flat cells lining the oesophagus)
- Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
- Mucosal inflammation (infection of mucous membrane)
- Pain
- Rectal haemorrhage (bleeding from anus)
- Venoocclusive liver disease (small veins in the liver are obstructed)
- Abdominal distension
2-9:
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
- Drug ineffective
- Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Periorbital oedema (swelling around the eyes)
- Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
10-19:
- Bacteraemia (presence of bacteria in the blood)
- Viraemia (presence of a virus in the blood stream)
- Blood lactate dehydrogenase increased
- Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
- Hypertension (high blood pressure)
- Lung disorder (lung disease)
- Oesophagitis (inflammation of oesophagus)
- Renal failure (kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Retinopathy (acute damage to the retina of the eye)
20-29:
- Oesophagitis (inflammation of oesophagus)
30-39:
n/a
40-49:
- Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
- Engraftment syndrome (inflammatory condition during neutrophil recovery after hematopoietic stem cell transplantation)
- Febrile neutropenia (fever with reduced white blood cells)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Cystitis viral (inflammation of the wall of the bladder by virus)
- Human herpesvirus 6 infection
- Rash
- Septic shock (shock due to blood infection)
- Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
50-59:
- Chills (felling of cold)
- Hypotension (abnormally low blood pressure)
- Infusion related reaction
- Pneumonia
- Pyrexia (fever)
- Acute respiratory distress syndrome
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
- Mucosal inflammation (infection of mucous membrane)
- Nausea (feeling of having an urge to vomit)
60+:
- Arthralgia (joint pain)
- Hypoxia (low oxygen in tissues)
- Prostatic specific antigen increased
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Abscess neck (neck abscesses)
- Anaemia of chronic disease
- Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
- Aortic arteriosclerosis (hardening of the aortic arteries)
- Aortic dilatation
- Arrhythmia (irregular heartbeat)
What are the existing conditions these people have? *
- Bone Marrow Conditioning Regimen: 22 people, 29.33%
- Peripheral T-Cell Lymphoma Unspecified Stage Iv (peripheral t-cell cancer unspecified stage iv): 15 people, 20.00%
- Multiple Myeloma (cancer of the plasma cells): 12 people, 16.00%
- Retinoblastoma (tumour of retina): 7 people, 9.33%
- Hypotension (abnormally low blood pressure): 7 people, 9.33%
- Fever: 7 people, 9.33%
- Disease Progression: 6 people, 8.00%
- Burkitt's Lymphoma (cancer of the lymphatic system): 5 people, 6.67%
- Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 6.67%
- Mucosal Inflammation (infection of mucous membrane): 4 people, 5.33%
* Approximation only. Some reports may have incomplete information.
Do you take Melphalan and Hydrocortisone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Melphalan (20,052 reports)
- Hydrocortisone (40,425 reports)
Browse all drug interactions of Melphalan and Hydrocortisone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Melphalan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Hydrocortisone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Melphalan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Hydrocortisone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on melphalan and hydrocortisone (the active ingredients of Melphalan and Hydrocortisone, respectively), and Melphalan and Hydrocortisone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Methocarbamol and Imitrex - 12 seconds ago
- Drug interactions of Eylea and Klor-Con - 17 seconds ago
- Could Lupron Depot cause Epilepsy Aggravated? - 18 seconds ago
- Could Acetylcarnitine cause Joint Pain? - 21 seconds ago
- Could Kadian cause Upper Respiratory Tract Infection? - 25 seconds ago
- Diphen vs. Triazolam, side effect and effectiveness comparison - 30 seconds ago
- Drug interactions of Onglyza and Nitrostat - 45 seconds ago
- Drug interactions of Ortho Tri-Cyclen and Augmentin '125' - 48 seconds ago
- Drug interactions of Gemcitabine and Fentanyl-100 - 57 seconds ago
- Drug interactions of Invanz and Vicodin - a minute ago